ABSTRACT
This article provides information about a scientific study conducted to explore the possibility of using photohemotherapy (UV blood irradiation) to correct hemostasis in the complex treatment of the SARS-CoV-2 coronavirus. The study included 21 patients diagnosed with SARS-CoV-2. The patients consisted of two groups: the main group (11 people), in which ultraviolet exposure to the blood was carried out in combination with the basic therapy, and the control group (10 people), where the treatment was used in accordance with the generally accepted basic therapy. The dynamics of stabilization of the parameters of the hemostasis system, the normalization of the acid-base durability of the blood, and the maximum saturation of erythrocyte hemoglobin were evaluated in comparison with the treatment results of patients in the control group. It was established that in patients with COVID-19 who underwent basic therapy in combination with intravenous UV irradiation of blood, in addition to improvement in the condition of the above systems, the following were noted: healing in CT scans of both lungs and negative PCR results in the study of swabs from the oropharynx and nasopharynx started 5-6 days earlier than in patients of the control group. Patients of the main group can be discharged after normalization of vital functions, CT scan of the lungs, and clinical and laboratory parameters 5-6 days earlier than patients in the control group.Copyright © 2022 Authors. All rights reserved.
ABSTRACT
This article provides information about a scientific study conducted to explore the possibility of using photohemotherapy (UV blood irradiation) to correct hemostasis in the complex treatment of the SARS-CoV-2 coronavirus. The study included 21 patients diagnosed with SARS-CoV-2. The patients consisted of two groups: the main group (11 people), in which ultraviolet exposure to the blood was carried out in combination with the basic therapy, and the control group (10 people), where the treatment was used in accordance with the generally accepted basic therapy. The dynamics of stabilization of the parameters of the hemostasis system, the normalization of the acid-base durability of the blood, and the maximum saturation of erythrocyte hemoglobin were evaluated in comparison with the treatment results of patients in the control group. It was established that in patients with COVID-19 who underwent basic therapy in combination with intravenous UV irradiation of blood, in addition to improvement in the condition of the above systems, the following were noted: healing in CT scans of both lungs and negative PCR results in the study of swabs from the oropharynx and nasopharynx started 5-6 days earlier than in patients of the control group. Patients of the main group can be discharged after normalization of vital functions, CT scan of the lungs, and clinical and laboratory parameters 5-6 days earlier than patients in the control group.Copyright © 2022 Authors. All rights reserved.
ABSTRACT
This article provides information about a scientific study conducted to explore the possibility of using photohemotherapy (UV blood irradiation) to correct hemostasis in the complex treatment of the SARS-CoV-2 coronavirus. The study included 21 patients diagnosed with SARS-CoV-2. The patients consisted of two groups: the main group (11 people), in which ultraviolet exposure to the blood was carried out in combination with the basic therapy, and the control group (10 people), where the treatment was used in accordance with the generally accepted basic therapy. The dynamics of stabilization of the parameters of the hemostasis system, the normalization of the acid-base durability of the blood, and the maximum saturation of erythrocyte hemoglobin were evaluated in comparison with the treatment results of patients in the control group. It was established that in patients with COVID-19 who underwent basic therapy in combination with intravenous UV irradiation of blood, in addition to improvement in the condition of the above systems, the following were noted: healing in CT scans of both lungs and negative PCR results in the study of swabs from the oropharynx and nasopharynx started 5-6 days earlier than in patients of the control group. Patients of the main group can be discharged after normalization of vital functions, CT scan of the lungs, and clinical and laboratory parameters 5-6 days earlier than patients in the control group.Copyright © 2022 Authors. All rights reserved.